Expertise in
2
conditions

Christoph Renner

Zuerich (kreis 7) / Hirslanden, ZH, CH 
Expertise in
2
conditions
Zuerich (kreis 7) / Hirslanden, ZH, CH 

Overview

Christoph Renner practices practicing medicine in Zuerich (kreis 7) / Hirslanden, Switzerland.

Mr. Renner is highly rated in 2 conditions, according to our data. His clinical expertise encompasses Multiple Myeloma, Mesothelioma, Hodgkin Lymphoma, Non-Hodgkin Lymphoma, and Bone Marrow Transplant.

He is actively involved in clinical research, co-authoring 93 peer reviewed articles and participating in 4 clinical trials.

Gender

Male

Locations

Zuerich (kreis 7) / Hirslanden, ZH, Switzerland
Other Locations
Geneve, GE 1211, Switzerland
Basel, BS 4031, Switzerland
Zurich, ZH, Switzerland
Steinhausen, ZG, Switzerland
Aarau, AG, Switzerland

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

Rituximab With or Without Ibrutinib for Untreated Patients With Advanced Follicular Lymphoma in Need of Therapy. A Randomized, Double-blinded, SAKK and NLG Collaborative Phase II Trial.
Rituximab With or Without Ibrutinib for Untreated Patients With Advanced Follicular Lymphoma in Need of Therapy. A Randomized, Double-blinded, SAKK and NLG Collaborative Phase II Trial.
Enrollment Status: Terminated
Publish Date: March 13, 2024
Intervention Type: Drug
Study Drugs: Ibrutinib, Rituximab
Study Phase: Phase 2
Combination of Ibrutinib and Bortezomib Followed by Ibrutinib Maintenance to Treat Patients With Relapsed and Refractory Mantle Cell Lymphoma; a Multicenter Phase I/II Trial.
Combination of Ibrutinib and Bortezomib Followed by Ibrutinib Maintenance to Treat Patients With Relapsed and Refractory Mantle Cell Lymphoma; a Multicenter Phase I/II Trial.
Enrollment Status: Terminated
Publish Date: March 11, 2022
Intervention Type: Drug
Study Drugs: Ibrutinib, Bortezomib
Study Phase: Phase 1/Phase 2
Validation of the Myeloma Patient Outcome Scale (MyPOS) Assessing the Quality of Life in Patients With Multiple Myeloma in the German Speaking Part of Switzerland
Validation of the Myeloma Patient Outcome Scale (MyPOS) Assessing the Quality of Life in Patients With Multiple Myeloma in the German Speaking Part of Switzerland
Enrollment Status: Terminated
Publish Date: October 14, 2021
Intervention Type: Diagnostic test
Alternate Day Dosing of Pomalidomide in Patients With Refractory Multiple Myeloma. A Multi-center, Single Arm Phase II Trial
Alternate Day Dosing of Pomalidomide in Patients With Refractory Multiple Myeloma. A Multi-center, Single Arm Phase II Trial
Enrollment Status: Terminated
Publish Date: June 10, 2021
Intervention Type: Drug
Study Drugs: Pomalidomide, Dexamethasone
Study Phase: Phase 2
View 3 Less Clinical Trials

93 Total Publications

Tuning Competing Electronic Phases in Monolayer VSe2 via Interface Hybridization.
Tuning Competing Electronic Phases in Monolayer VSe2 via Interface Hybridization.
Journal: ACS nano
Published: March 03, 2026

Frequently Asked Questions about Christoph Renner

Is Christoph Renner a top-rated expert for Multiple Myeloma?

MediFind is an objective health platform that identifies experts based on real-world data. Christoph Renner is classified as an Advanced expert for Multiple Myeloma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Christoph Renner participate in research or clinical trials?

Yes. Christoph Renner has published 93 articles and abstracts on conditions like Multiple Myeloma. You can view a list of Christoph Renner's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Renner's expertise for a condition
ConditionClose
      View All 19 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile